Anupam Rasayan India Limited announces an acquisition
TL;DR
According to the Post-Offer Advertisement, what was the final number of shares tendered by public shareholders compared to the total number of shares proposed to be acquired in the Detailed Public Statement, and what was the final acceptance ratio?
The final number of shares tendered by public shareholders was 1,669, versus 2,77,26,848 shares proposed to be acquired under the Detailed Public Statement [1].
- Final acceptance ratio versus proposed offer size: approximately 0.0060% (1,669 ÷ 2,77,26,848).
- Acceptance of shares actually tendered: 100%, since all 1,669 tendered shares were accepted [1].
What is the total cash consideration paid for the shares acquired through this open offer, and how does this specific outflow reconcile with the cash and cash equivalents reported in the company's most recent balance sheet?
The actual cash consideration paid was Rs 4,99,031, for 1,669 shares acquired at Rs 299 per share—equivalent to approximately Rs 0.05 Crore. This is the realised payment, not the maximum potential open-offer consideration of Rs 829.03 Crore. [2]
Against the latest reported Q1 FY27 consolidated cash and cash equivalents of Rs 378.07 Crore, the payment represented approximately 0.01% of the reported cash balance. [3]
Mechanically:
- Consolidated cash before payment: Rs 378.07 Crore [3]
- Less: open-offer consideration: Rs 0.05 Crore [2]
- Illustrative cash after this payment, assuming no other movements: Rs 378.02 Crore *(derived)*
Thus, this specific open-offer outflow is immaterial relative to the reported consolidated cash balance and does not, by itself, explain any meaningful change in liquidity. The Rs 378.02 Crore figure is only a mechanical bridge; the balance sheet cash was reported for Q1 FY27, while the payment relates to the later offer settlement, and actual post-payment cash would also reflect operating, investing, financing and other transaction flows.
Post-acquisition, what is the final aggregate shareholding percentage of the acquirer in the target company, and does the Letter of Offer specify any immediate changes to the target's board composition or operational control?
The final post-offer aggregate holding was reported at 0.00% of Bliss GVS Pharma’s expanded voting share capital: Anupam Rasayan held 1,669 shares, while the PAC held none. No shares were acquired under the underlying agreements, and only 1,669 shares were accepted in the open offer [4].
On board composition and operational control, the cited post-offer advertisement only references the Letter of Offer; it does not reproduce any provision specifying an immediate board reconstitution, change in management, or transfer of operational control. Accordingly, no immediate change is evidenced in the disclosed post-offer outcome; the Letter of Offer’s detailed governance provisions would need to be reviewed separately for a definitive contractual position [4].
Sources
- [1]Post-Offer Advertisement for Bliss GVS Pharma Limited Open Offer by Anupam Rasayan India Limited — 2026-09-01T20:05:14, p.2
- [2]Anupam Rasayan acquires 1669 Bliss GVS Pharma ... — Scanx, 2026-09-01T20:04:48.645733
- [3]Latest Cash and Equivalents
- [4]Post-Offer Advertisement for Bliss GVS Pharma Limited Open Offer by Anupam Rasayan India Limited — 2026-09-01T20:05:14, p.3
Keep digging
